FOLH1 and neoplasm: F-18 florastamin (F-18 FC303) is an emerging PSMA-targeted diagnostic radioligand that exhibits a higher tumor-to-background contrast as compared to F-18 DCFPyL, facilitating superior detection of osseous metastases, small metastatic lymph nodes, and primary tumors on delayed imaging [54].